Bio news hits surprising headlines: Google’s Venture fund is planning to invest $1 billion in a wide-range of start-ups over the next five years, but the firm isn’t necessarily looking for the next Facebook, Twitter or other media related business.
“There’s a whole world of innovation out there outside of social media. It’s a huge growth area, but we’re investing a lot of money in life sciences,” said William Maris, Google Ventures managing partner.
While GoogleVentures, which is currently invested in over 100 companies, is invested in some social media companies, Maris said the fund seeks entrepreneurs that “have a healthy disregard for the impossible” with forward-thinking ideas, especially in biotech.
Maris said some of the areas he is interested in include businesses that are focused on radical life extension, cryogenics and nanotechnology as further reported in the bio news article.
One biotech company Google Ventures is invested in is Foundation Medicine, a molecular information company that is focused on personalized cancer diagnosis so that patients can receive personalized cancer treatments.
“Part of my job is to discern the fine line between crazy and genius,” Maris said. “We’re looking for entrepreneurs that want to change the world for the better and that’s important. So I do think our values are a little bit different than the typical sort of venture capitalist you might meet.”
For further deal information visit Current Agreements (subscription required)
Read: more on dealtalk in pharma, biotech, life science partnering deal news, insights and glossary
View: Current Partnering’s Partnering Scorecard – view top life science partnering deals by value
View: Current Partnering’s Deal Metrics – the latest deal trend infographics for life science deal making
View: Current Partnering’s Big Pharma Deal Making Scorecard – latest trends in big pharma deal making activity